| Pharmaceutical active ingredients: |
| SulfabenzamideSulfacetamideSulfathiazole |
| Available forms, composition and doses of Triple Sulfa: |
| Cream; Topical; Vaginal; Sulfabenzamide 3.7%; Sulfacetamide 2.86%; Sulfathiazole 3.42%Tablets; Oral; Vaginal; Sulfabenzamide 184 mg; Sulfacetamide 143.75 mg; Sulfathiazole 172.5 mg |
| Triple Sulfa medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Fougera |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vepar | Suleparoid | Istituto Biochimico Nazionale Savio |
| Alba Gyn | Sulfabenzamide; Sulfacetamide; Sulfathiazole | A.J. Bart |
| Gyne-Sulf | Sulfabenzamide; Sulfacetamide; Sulfathiazole | G & W Laboratories |
| Sultrin | Sulfabenzamide; Sulfacetamide; Sulfathiazole | Janssen; Ortho McNeil Pharmaceuticals |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | Clay-Park Laboratories |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | IVAX |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | NMC Laboratories |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | PharmaDerm |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | The Harvard Drug Group |
| Triple Sulfa | Sulfabenzamide; Sulfacetamide; Sulfathiazole | Watson Pharmaceuticals |